Global Leukocyte Surface Antigen CD47 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Leukocyte Surface Antigen CD47 market size was valued at US$ 33.96 million in 2025 and is forecast to a readjusted size of US$ 65.51 million by 2032 with a CAGR of 9.8% during review period.
Leukocyte Surface Antigen CD47 refers to a biologically and commercially defined target centered on the CD47 antigen. In the market, the sellable products are usually not the native antigen in the human body itself, but antibodies, recombinant proteins, assay kits, binding reagents, and preclinical or clinical blocking molecules developed around this target. The native molecule is a broadly expressed glycosylated transmembrane protein on the cell surface; commercial forms are commonly clear to slightly opalescent liquids, lyophilized powders, or pre-coated microplate kits. Structurally, it contains an extracellular immunoglobulin-like domain, multiple transmembrane regions, and a short intracellular tail. Its product composition may include mammalian-cell-expressed recombinant protein, hybridoma-derived or recombinantly expressed monoclonal antibodies, fluorescent or enzyme-conjugated antibodies, and engineered fusion proteins. Leukocyte Surface Antigen CD47 products belong to life-science research reagents, immunoassay raw materials, and oncology immunotherapy target-development materials. Key technical requirements include high purity, lot-to-lot consistency, correct conformation, low endotoxin, defined species reactivity, and validated binding activity. Its functional principle is to detect or modulate the interaction between this antigen and phagocyte receptors, supporting cell phenotyping, tissue staining, antibody screening, binding-kinetics testing, tumor-immunology research, and candidate-drug evaluation.
Market opportunities are mainly driven by the extension of oncology immunology from adaptive immune checkpoints to innate immune checkpoints. Leukocyte Surface Antigen CD47 is linked to phagocytosis-suppressive signaling, so it supports basic research, flow-cytometry detection, tissue staining, antibody screening, and candidate-drug evaluation. As combination therapy, biomarker stratification, and low red-blood-cell binding designs become the focus of development, research antibodies, recombinant proteins, binding-assay materials, and preclinical functional antibodies still have room for steady growth. For suppliers, the key opportunity is not ordinary catalog antibodies alone, but high-consistency, low-endotoxin, clone-defined, cross-species-validated, and functionally blocking product portfolios.
The main challenge is that the target is broadly expressed, making the therapeutic window narrower than many tumor-specific targets. Failures, discontinuations, and clinical holds in representative candidate drugs have reset investor expectations and reduced the credibility of early high-growth assumptions. In therapeutic development, major risks include anemia, platelet effects, red-blood-cell binding, insufficient monotherapy efficacy, complex combination strategies, difficult patient enrollment, and delayed commercialization. The research reagent segment is less directly affected, but when drug pipelines contract, demand for screening reagents and translational-research materials can become more project-driven and volatile.
Downstream demand is expected to become more segmented. Basic research, immunology, hematology, and tumor-microenvironment studies will continue to generate routine purchases of antibodies, recombinant proteins, and assay kits, usually in small-batch and multi-specification formats. Drug-development customers will place greater emphasis on traceable manufacturing, functional validation, low endotoxin, cell-binding activity, and customized compatibility with candidate screening. Future growth is more likely to come from high-quality tool products, companion research materials, preclinical efficacy evaluation, and combination-immunotherapy research, rather than from near-term large-scale commercial drug sales.
This report is a detailed and comprehensive analysis for global Leukocyte Surface Antigen CD47 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Leukocyte Surface Antigen CD47 market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Leukocyte Surface Antigen CD47 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Leukocyte Surface Antigen CD47 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Leukocyte Surface Antigen CD47, with price, sales quantity, revenue, and global market share of Leukocyte Surface Antigen CD47 from 2021 to 2026.
Chapter 3, the Leukocyte Surface Antigen CD47 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leukocyte Surface Antigen CD47 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Leukocyte Surface Antigen CD47 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Leukocyte Surface Antigen CD47.
Chapter 14 and 15, to describe Leukocyte Surface Antigen CD47 sales channel, distributors, customers, research findings and conclusion.
Leukocyte Surface Antigen CD47 refers to a biologically and commercially defined target centered on the CD47 antigen. In the market, the sellable products are usually not the native antigen in the human body itself, but antibodies, recombinant proteins, assay kits, binding reagents, and preclinical or clinical blocking molecules developed around this target. The native molecule is a broadly expressed glycosylated transmembrane protein on the cell surface; commercial forms are commonly clear to slightly opalescent liquids, lyophilized powders, or pre-coated microplate kits. Structurally, it contains an extracellular immunoglobulin-like domain, multiple transmembrane regions, and a short intracellular tail. Its product composition may include mammalian-cell-expressed recombinant protein, hybridoma-derived or recombinantly expressed monoclonal antibodies, fluorescent or enzyme-conjugated antibodies, and engineered fusion proteins. Leukocyte Surface Antigen CD47 products belong to life-science research reagents, immunoassay raw materials, and oncology immunotherapy target-development materials. Key technical requirements include high purity, lot-to-lot consistency, correct conformation, low endotoxin, defined species reactivity, and validated binding activity. Its functional principle is to detect or modulate the interaction between this antigen and phagocyte receptors, supporting cell phenotyping, tissue staining, antibody screening, binding-kinetics testing, tumor-immunology research, and candidate-drug evaluation.
Market opportunities are mainly driven by the extension of oncology immunology from adaptive immune checkpoints to innate immune checkpoints. Leukocyte Surface Antigen CD47 is linked to phagocytosis-suppressive signaling, so it supports basic research, flow-cytometry detection, tissue staining, antibody screening, and candidate-drug evaluation. As combination therapy, biomarker stratification, and low red-blood-cell binding designs become the focus of development, research antibodies, recombinant proteins, binding-assay materials, and preclinical functional antibodies still have room for steady growth. For suppliers, the key opportunity is not ordinary catalog antibodies alone, but high-consistency, low-endotoxin, clone-defined, cross-species-validated, and functionally blocking product portfolios.
The main challenge is that the target is broadly expressed, making the therapeutic window narrower than many tumor-specific targets. Failures, discontinuations, and clinical holds in representative candidate drugs have reset investor expectations and reduced the credibility of early high-growth assumptions. In therapeutic development, major risks include anemia, platelet effects, red-blood-cell binding, insufficient monotherapy efficacy, complex combination strategies, difficult patient enrollment, and delayed commercialization. The research reagent segment is less directly affected, but when drug pipelines contract, demand for screening reagents and translational-research materials can become more project-driven and volatile.
Downstream demand is expected to become more segmented. Basic research, immunology, hematology, and tumor-microenvironment studies will continue to generate routine purchases of antibodies, recombinant proteins, and assay kits, usually in small-batch and multi-specification formats. Drug-development customers will place greater emphasis on traceable manufacturing, functional validation, low endotoxin, cell-binding activity, and customized compatibility with candidate screening. Future growth is more likely to come from high-quality tool products, companion research materials, preclinical efficacy evaluation, and combination-immunotherapy research, rather than from near-term large-scale commercial drug sales.
This report is a detailed and comprehensive analysis for global Leukocyte Surface Antigen CD47 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Leukocyte Surface Antigen CD47 market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Leukocyte Surface Antigen CD47 market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Leukocyte Surface Antigen CD47
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Leukocyte Surface Antigen CD47 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- B-6H12
- ALX-148
- CC-90002
- PSTx-23
- Others
- Anti-CD47 Antibodies
- Recombinant CD47 Proteins
- CD47 Assay Kits
- Others
- Antibodies
- Fusion Proteins
- Small Molecules and Peptides
- Others
- Mammalian Cell Expression Products
- Hybridoma-derived Products
- Microbial Expression Products
- Others
- Lymphoma
- Ovarian Cancer
- Ischemia Reperfusion Injury
- Kindney Transplant Rejection
- Others
- Thermo Fisher Scientific
- Merck
- BD Biosciences
- Bio-Techne
- Bio-Rad
- Revvity BioLegend
- Abcam
- Miltenyi Biotec
- Cell Signaling Technology
- Proteintech
- Sino Biological
- ACROBiosystems
- MedChemExpress
- OriGene
- Santa Cruz Biotechnology
- Bio X Cell
- Leinco Technologies
- RayBiotech
- Cytek Biosciences
- Biocare Medical
- Creative Biolabs
- BPS Bioscience
- MyBioSource
- Novus Biologicals
- Aviva Systems Biology
- Bioss
- Innovative Research
- Antibodies.com
- Abbexa
- Arigo Biolaboratories
- Abnova
- CUSABIO
- Elabscience
- Boster Biological Technology
- ABclonal
- Sangon Biotech
- Cloud-Clone
- Akeso
- 3D Medicines
- Fapon Biopharma
- Aurigene Oncology
- ALX Oncology
- ImmuneOncia Therapeutics
- Boehringer Ingelheim
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Leukocyte Surface Antigen CD47 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Leukocyte Surface Antigen CD47, with price, sales quantity, revenue, and global market share of Leukocyte Surface Antigen CD47 from 2021 to 2026.
Chapter 3, the Leukocyte Surface Antigen CD47 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leukocyte Surface Antigen CD47 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Leukocyte Surface Antigen CD47 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Leukocyte Surface Antigen CD47.
Chapter 14 and 15, to describe Leukocyte Surface Antigen CD47 sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 B-6H12
1.3.3 ALX-148
1.3.4 CC-90002
1.3.5 PSTx-23
1.3.6 Others
1.4 Market Analysis by Commercial Product Form
1.4.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Commercial Product Form: 2021 Versus 2025 Versus 2032
1.4.2 Anti-CD47 Antibodies
1.4.3 Recombinant CD47 Proteins
1.4.4 CD47 Assay Kits
1.4.5 Others
1.5 Market Analysis by Molecular Modality
1.5.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Molecular Modality: 2021 Versus 2025 Versus 2032
1.5.2 Antibodies
1.5.3 Fusion Proteins
1.5.4 Small Molecules and Peptides
1.5.5 Others
1.6 Market Analysis by Manufacturing System
1.6.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Manufacturing System: 2021 Versus 2025 Versus 2032
1.6.2 Mammalian Cell Expression Products
1.6.3 Hybridoma-derived Products
1.6.4 Microbial Expression Products
1.6.5 Others
1.7 Market Analysis by Application
1.7.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Lymphoma
1.7.3 Ovarian Cancer
1.7.4 Ischemia Reperfusion Injury
1.7.5 Kindney Transplant Rejection
1.7.6 Others
1.8 Global Leukocyte Surface Antigen CD47 Market Size & Forecast
1.8.1 Global Leukocyte Surface Antigen CD47 Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Leukocyte Surface Antigen CD47 Sales Quantity (2021-2032)
1.8.3 Global Leukocyte Surface Antigen CD47 Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
2.1.4 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Leukocyte Surface Antigen CD47 Product and Services
2.2.4 Merck Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck Recent Developments/Updates
2.3 BD Biosciences
2.3.1 BD Biosciences Details
2.3.2 BD Biosciences Major Business
2.3.3 BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
2.3.4 BD Biosciences Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Biosciences Recent Developments/Updates
2.4 Bio-Techne
2.4.1 Bio-Techne Details
2.4.2 Bio-Techne Major Business
2.4.3 Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
2.4.4 Bio-Techne Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Techne Recent Developments/Updates
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
2.5.4 Bio-Rad Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Bio-Rad Recent Developments/Updates
2.6 Revvity BioLegend
2.6.1 Revvity BioLegend Details
2.6.2 Revvity BioLegend Major Business
2.6.3 Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
2.6.4 Revvity BioLegend Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Revvity BioLegend Recent Developments/Updates
2.7 Abcam
2.7.1 Abcam Details
2.7.2 Abcam Major Business
2.7.3 Abcam Leukocyte Surface Antigen CD47 Product and Services
2.7.4 Abcam Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Abcam Recent Developments/Updates
2.8 Miltenyi Biotec
2.8.1 Miltenyi Biotec Details
2.8.2 Miltenyi Biotec Major Business
2.8.3 Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
2.8.4 Miltenyi Biotec Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Miltenyi Biotec Recent Developments/Updates
2.9 Cell Signaling Technology
2.9.1 Cell Signaling Technology Details
2.9.2 Cell Signaling Technology Major Business
2.9.3 Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
2.9.4 Cell Signaling Technology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cell Signaling Technology Recent Developments/Updates
2.10 Proteintech
2.10.1 Proteintech Details
2.10.2 Proteintech Major Business
2.10.3 Proteintech Leukocyte Surface Antigen CD47 Product and Services
2.10.4 Proteintech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Proteintech Recent Developments/Updates
2.11 Sino Biological
2.11.1 Sino Biological Details
2.11.2 Sino Biological Major Business
2.11.3 Sino Biological Leukocyte Surface Antigen CD47 Product and Services
2.11.4 Sino Biological Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sino Biological Recent Developments/Updates
2.12 ACROBiosystems
2.12.1 ACROBiosystems Details
2.12.2 ACROBiosystems Major Business
2.12.3 ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
2.12.4 ACROBiosystems Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 ACROBiosystems Recent Developments/Updates
2.13 MedChemExpress
2.13.1 MedChemExpress Details
2.13.2 MedChemExpress Major Business
2.13.3 MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
2.13.4 MedChemExpress Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 MedChemExpress Recent Developments/Updates
2.14 OriGene
2.14.1 OriGene Details
2.14.2 OriGene Major Business
2.14.3 OriGene Leukocyte Surface Antigen CD47 Product and Services
2.14.4 OriGene Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 OriGene Recent Developments/Updates
2.15 Santa Cruz Biotechnology
2.15.1 Santa Cruz Biotechnology Details
2.15.2 Santa Cruz Biotechnology Major Business
2.15.3 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
2.15.4 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Santa Cruz Biotechnology Recent Developments/Updates
2.16 Bio X Cell
2.16.1 Bio X Cell Details
2.16.2 Bio X Cell Major Business
2.16.3 Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
2.16.4 Bio X Cell Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Bio X Cell Recent Developments/Updates
2.17 Leinco Technologies
2.17.1 Leinco Technologies Details
2.17.2 Leinco Technologies Major Business
2.17.3 Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
2.17.4 Leinco Technologies Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Leinco Technologies Recent Developments/Updates
2.18 RayBiotech
2.18.1 RayBiotech Details
2.18.2 RayBiotech Major Business
2.18.3 RayBiotech Leukocyte Surface Antigen CD47 Product and Services
2.18.4 RayBiotech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 RayBiotech Recent Developments/Updates
2.19 Cytek Biosciences
2.19.1 Cytek Biosciences Details
2.19.2 Cytek Biosciences Major Business
2.19.3 Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
2.19.4 Cytek Biosciences Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cytek Biosciences Recent Developments/Updates
2.20 Biocare Medical
2.20.1 Biocare Medical Details
2.20.2 Biocare Medical Major Business
2.20.3 Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
2.20.4 Biocare Medical Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Biocare Medical Recent Developments/Updates
2.21 Creative Biolabs
2.21.1 Creative Biolabs Details
2.21.2 Creative Biolabs Major Business
2.21.3 Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
2.21.4 Creative Biolabs Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Creative Biolabs Recent Developments/Updates
2.22 BPS Bioscience
2.22.1 BPS Bioscience Details
2.22.2 BPS Bioscience Major Business
2.22.3 BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
2.22.4 BPS Bioscience Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 BPS Bioscience Recent Developments/Updates
2.23 MyBioSource
2.23.1 MyBioSource Details
2.23.2 MyBioSource Major Business
2.23.3 MyBioSource Leukocyte Surface Antigen CD47 Product and Services
2.23.4 MyBioSource Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 MyBioSource Recent Developments/Updates
2.24 Novus Biologicals
2.24.1 Novus Biologicals Details
2.24.2 Novus Biologicals Major Business
2.24.3 Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
2.24.4 Novus Biologicals Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Novus Biologicals Recent Developments/Updates
2.25 Aviva Systems Biology
2.25.1 Aviva Systems Biology Details
2.25.2 Aviva Systems Biology Major Business
2.25.3 Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
2.25.4 Aviva Systems Biology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Aviva Systems Biology Recent Developments/Updates
2.26 Bioss
2.26.1 Bioss Details
2.26.2 Bioss Major Business
2.26.3 Bioss Leukocyte Surface Antigen CD47 Product and Services
2.26.4 Bioss Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Bioss Recent Developments/Updates
2.27 Innovative Research
2.27.1 Innovative Research Details
2.27.2 Innovative Research Major Business
2.27.3 Innovative Research Leukocyte Surface Antigen CD47 Product and Services
2.27.4 Innovative Research Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Innovative Research Recent Developments/Updates
2.28 Antibodies.com
2.28.1 Antibodies.com Details
2.28.2 Antibodies.com Major Business
2.28.3 Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
2.28.4 Antibodies.com Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Antibodies.com Recent Developments/Updates
2.29 Abbexa
2.29.1 Abbexa Details
2.29.2 Abbexa Major Business
2.29.3 Abbexa Leukocyte Surface Antigen CD47 Product and Services
2.29.4 Abbexa Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Abbexa Recent Developments/Updates
2.30 Arigo Biolaboratories
2.30.1 Arigo Biolaboratories Details
2.30.2 Arigo Biolaboratories Major Business
2.30.3 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
2.30.4 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Arigo Biolaboratories Recent Developments/Updates
2.31 Abnova
2.31.1 Abnova Details
2.31.2 Abnova Major Business
2.31.3 Abnova Leukocyte Surface Antigen CD47 Product and Services
2.31.4 Abnova Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Abnova Recent Developments/Updates
2.32 CUSABIO
2.32.1 CUSABIO Details
2.32.2 CUSABIO Major Business
2.32.3 CUSABIO Leukocyte Surface Antigen CD47 Product and Services
2.32.4 CUSABIO Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 CUSABIO Recent Developments/Updates
2.33 Elabscience
2.33.1 Elabscience Details
2.33.2 Elabscience Major Business
2.33.3 Elabscience Leukocyte Surface Antigen CD47 Product and Services
2.33.4 Elabscience Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Elabscience Recent Developments/Updates
2.34 Boster Biological Technology
2.34.1 Boster Biological Technology Details
2.34.2 Boster Biological Technology Major Business
2.34.3 Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
2.34.4 Boster Biological Technology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Boster Biological Technology Recent Developments/Updates
2.35 ABclonal
2.35.1 ABclonal Details
2.35.2 ABclonal Major Business
2.35.3 ABclonal Leukocyte Surface Antigen CD47 Product and Services
2.35.4 ABclonal Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 ABclonal Recent Developments/Updates
2.36 Sangon Biotech
2.36.1 Sangon Biotech Details
2.36.2 Sangon Biotech Major Business
2.36.3 Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
2.36.4 Sangon Biotech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Sangon Biotech Recent Developments/Updates
2.37 Cloud-Clone
2.37.1 Cloud-Clone Details
2.37.2 Cloud-Clone Major Business
2.37.3 Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
2.37.4 Cloud-Clone Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 Cloud-Clone Recent Developments/Updates
2.38 Akeso
2.38.1 Akeso Details
2.38.2 Akeso Major Business
2.38.3 Akeso Leukocyte Surface Antigen CD47 Product and Services
2.38.4 Akeso Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Akeso Recent Developments/Updates
2.39 3D Medicines
2.39.1 3D Medicines Details
2.39.2 3D Medicines Major Business
2.39.3 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
2.39.4 3D Medicines Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 3D Medicines Recent Developments/Updates
2.40 Fapon Biopharma
2.40.1 Fapon Biopharma Details
2.40.2 Fapon Biopharma Major Business
2.40.3 Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
2.40.4 Fapon Biopharma Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Fapon Biopharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LEUKOCYTE SURFACE ANTIGEN CD47 BY MANUFACTURER
3.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Manufacturer (2021-2026)
3.2 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturer (2021-2026)
3.3 Global Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2025
3.4.3 Top 6 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2025
3.5 Leukocyte Surface Antigen CD47 Market: Overall Company Footprint Analysis
3.5.1 Leukocyte Surface Antigen CD47 Market: Region Footprint
3.5.2 Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
3.5.3 Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Leukocyte Surface Antigen CD47 Market Size by Region
4.1.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2032)
4.1.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2032)
4.1.3 Global Leukocyte Surface Antigen CD47 Average Price by Region (2021-2032)
4.2 North America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.3 Europe Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.4 Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.5 South America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.6 Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
5.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2021-2032)
5.3 Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
6.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2021-2032)
6.3 Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
7.2 North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
7.3 North America Leukocyte Surface Antigen CD47 Market Size by Country
7.3.1 North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
7.3.2 North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
8.2 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
8.3 Europe Leukocyte Surface Antigen CD47 Market Size by Country
8.3.1 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
8.3.2 Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Region
9.3.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
10.2 South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
10.3 South America Leukocyte Surface Antigen CD47 Market Size by Country
10.3.1 South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
10.3.2 South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Leukocyte Surface Antigen CD47 Market Size by Country
11.3.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Leukocyte Surface Antigen CD47 Market Drivers
12.2 Leukocyte Surface Antigen CD47 Market Restraints
12.3 Leukocyte Surface Antigen CD47 Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Leukocyte Surface Antigen CD47 and Key Manufacturers
13.2 Manufacturing Costs Percentage of Leukocyte Surface Antigen CD47
13.3 Leukocyte Surface Antigen CD47 Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Leukocyte Surface Antigen CD47 Typical Distributors
14.3 Leukocyte Surface Antigen CD47 Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 B-6H12
1.3.3 ALX-148
1.3.4 CC-90002
1.3.5 PSTx-23
1.3.6 Others
1.4 Market Analysis by Commercial Product Form
1.4.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Commercial Product Form: 2021 Versus 2025 Versus 2032
1.4.2 Anti-CD47 Antibodies
1.4.3 Recombinant CD47 Proteins
1.4.4 CD47 Assay Kits
1.4.5 Others
1.5 Market Analysis by Molecular Modality
1.5.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Molecular Modality: 2021 Versus 2025 Versus 2032
1.5.2 Antibodies
1.5.3 Fusion Proteins
1.5.4 Small Molecules and Peptides
1.5.5 Others
1.6 Market Analysis by Manufacturing System
1.6.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Manufacturing System: 2021 Versus 2025 Versus 2032
1.6.2 Mammalian Cell Expression Products
1.6.3 Hybridoma-derived Products
1.6.4 Microbial Expression Products
1.6.5 Others
1.7 Market Analysis by Application
1.7.1 Overview: Global Leukocyte Surface Antigen CD47 Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Lymphoma
1.7.3 Ovarian Cancer
1.7.4 Ischemia Reperfusion Injury
1.7.5 Kindney Transplant Rejection
1.7.6 Others
1.8 Global Leukocyte Surface Antigen CD47 Market Size & Forecast
1.8.1 Global Leukocyte Surface Antigen CD47 Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Leukocyte Surface Antigen CD47 Sales Quantity (2021-2032)
1.8.3 Global Leukocyte Surface Antigen CD47 Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
2.1.4 Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Leukocyte Surface Antigen CD47 Product and Services
2.2.4 Merck Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck Recent Developments/Updates
2.3 BD Biosciences
2.3.1 BD Biosciences Details
2.3.2 BD Biosciences Major Business
2.3.3 BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
2.3.4 BD Biosciences Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BD Biosciences Recent Developments/Updates
2.4 Bio-Techne
2.4.1 Bio-Techne Details
2.4.2 Bio-Techne Major Business
2.4.3 Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
2.4.4 Bio-Techne Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Techne Recent Developments/Updates
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
2.5.4 Bio-Rad Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Bio-Rad Recent Developments/Updates
2.6 Revvity BioLegend
2.6.1 Revvity BioLegend Details
2.6.2 Revvity BioLegend Major Business
2.6.3 Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
2.6.4 Revvity BioLegend Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Revvity BioLegend Recent Developments/Updates
2.7 Abcam
2.7.1 Abcam Details
2.7.2 Abcam Major Business
2.7.3 Abcam Leukocyte Surface Antigen CD47 Product and Services
2.7.4 Abcam Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Abcam Recent Developments/Updates
2.8 Miltenyi Biotec
2.8.1 Miltenyi Biotec Details
2.8.2 Miltenyi Biotec Major Business
2.8.3 Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
2.8.4 Miltenyi Biotec Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Miltenyi Biotec Recent Developments/Updates
2.9 Cell Signaling Technology
2.9.1 Cell Signaling Technology Details
2.9.2 Cell Signaling Technology Major Business
2.9.3 Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
2.9.4 Cell Signaling Technology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cell Signaling Technology Recent Developments/Updates
2.10 Proteintech
2.10.1 Proteintech Details
2.10.2 Proteintech Major Business
2.10.3 Proteintech Leukocyte Surface Antigen CD47 Product and Services
2.10.4 Proteintech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Proteintech Recent Developments/Updates
2.11 Sino Biological
2.11.1 Sino Biological Details
2.11.2 Sino Biological Major Business
2.11.3 Sino Biological Leukocyte Surface Antigen CD47 Product and Services
2.11.4 Sino Biological Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sino Biological Recent Developments/Updates
2.12 ACROBiosystems
2.12.1 ACROBiosystems Details
2.12.2 ACROBiosystems Major Business
2.12.3 ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
2.12.4 ACROBiosystems Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 ACROBiosystems Recent Developments/Updates
2.13 MedChemExpress
2.13.1 MedChemExpress Details
2.13.2 MedChemExpress Major Business
2.13.3 MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
2.13.4 MedChemExpress Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 MedChemExpress Recent Developments/Updates
2.14 OriGene
2.14.1 OriGene Details
2.14.2 OriGene Major Business
2.14.3 OriGene Leukocyte Surface Antigen CD47 Product and Services
2.14.4 OriGene Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 OriGene Recent Developments/Updates
2.15 Santa Cruz Biotechnology
2.15.1 Santa Cruz Biotechnology Details
2.15.2 Santa Cruz Biotechnology Major Business
2.15.3 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
2.15.4 Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Santa Cruz Biotechnology Recent Developments/Updates
2.16 Bio X Cell
2.16.1 Bio X Cell Details
2.16.2 Bio X Cell Major Business
2.16.3 Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
2.16.4 Bio X Cell Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Bio X Cell Recent Developments/Updates
2.17 Leinco Technologies
2.17.1 Leinco Technologies Details
2.17.2 Leinco Technologies Major Business
2.17.3 Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
2.17.4 Leinco Technologies Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Leinco Technologies Recent Developments/Updates
2.18 RayBiotech
2.18.1 RayBiotech Details
2.18.2 RayBiotech Major Business
2.18.3 RayBiotech Leukocyte Surface Antigen CD47 Product and Services
2.18.4 RayBiotech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 RayBiotech Recent Developments/Updates
2.19 Cytek Biosciences
2.19.1 Cytek Biosciences Details
2.19.2 Cytek Biosciences Major Business
2.19.3 Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
2.19.4 Cytek Biosciences Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cytek Biosciences Recent Developments/Updates
2.20 Biocare Medical
2.20.1 Biocare Medical Details
2.20.2 Biocare Medical Major Business
2.20.3 Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
2.20.4 Biocare Medical Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Biocare Medical Recent Developments/Updates
2.21 Creative Biolabs
2.21.1 Creative Biolabs Details
2.21.2 Creative Biolabs Major Business
2.21.3 Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
2.21.4 Creative Biolabs Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Creative Biolabs Recent Developments/Updates
2.22 BPS Bioscience
2.22.1 BPS Bioscience Details
2.22.2 BPS Bioscience Major Business
2.22.3 BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
2.22.4 BPS Bioscience Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 BPS Bioscience Recent Developments/Updates
2.23 MyBioSource
2.23.1 MyBioSource Details
2.23.2 MyBioSource Major Business
2.23.3 MyBioSource Leukocyte Surface Antigen CD47 Product and Services
2.23.4 MyBioSource Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 MyBioSource Recent Developments/Updates
2.24 Novus Biologicals
2.24.1 Novus Biologicals Details
2.24.2 Novus Biologicals Major Business
2.24.3 Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
2.24.4 Novus Biologicals Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Novus Biologicals Recent Developments/Updates
2.25 Aviva Systems Biology
2.25.1 Aviva Systems Biology Details
2.25.2 Aviva Systems Biology Major Business
2.25.3 Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
2.25.4 Aviva Systems Biology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Aviva Systems Biology Recent Developments/Updates
2.26 Bioss
2.26.1 Bioss Details
2.26.2 Bioss Major Business
2.26.3 Bioss Leukocyte Surface Antigen CD47 Product and Services
2.26.4 Bioss Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Bioss Recent Developments/Updates
2.27 Innovative Research
2.27.1 Innovative Research Details
2.27.2 Innovative Research Major Business
2.27.3 Innovative Research Leukocyte Surface Antigen CD47 Product and Services
2.27.4 Innovative Research Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Innovative Research Recent Developments/Updates
2.28 Antibodies.com
2.28.1 Antibodies.com Details
2.28.2 Antibodies.com Major Business
2.28.3 Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
2.28.4 Antibodies.com Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Antibodies.com Recent Developments/Updates
2.29 Abbexa
2.29.1 Abbexa Details
2.29.2 Abbexa Major Business
2.29.3 Abbexa Leukocyte Surface Antigen CD47 Product and Services
2.29.4 Abbexa Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Abbexa Recent Developments/Updates
2.30 Arigo Biolaboratories
2.30.1 Arigo Biolaboratories Details
2.30.2 Arigo Biolaboratories Major Business
2.30.3 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
2.30.4 Arigo Biolaboratories Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Arigo Biolaboratories Recent Developments/Updates
2.31 Abnova
2.31.1 Abnova Details
2.31.2 Abnova Major Business
2.31.3 Abnova Leukocyte Surface Antigen CD47 Product and Services
2.31.4 Abnova Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Abnova Recent Developments/Updates
2.32 CUSABIO
2.32.1 CUSABIO Details
2.32.2 CUSABIO Major Business
2.32.3 CUSABIO Leukocyte Surface Antigen CD47 Product and Services
2.32.4 CUSABIO Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 CUSABIO Recent Developments/Updates
2.33 Elabscience
2.33.1 Elabscience Details
2.33.2 Elabscience Major Business
2.33.3 Elabscience Leukocyte Surface Antigen CD47 Product and Services
2.33.4 Elabscience Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Elabscience Recent Developments/Updates
2.34 Boster Biological Technology
2.34.1 Boster Biological Technology Details
2.34.2 Boster Biological Technology Major Business
2.34.3 Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
2.34.4 Boster Biological Technology Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Boster Biological Technology Recent Developments/Updates
2.35 ABclonal
2.35.1 ABclonal Details
2.35.2 ABclonal Major Business
2.35.3 ABclonal Leukocyte Surface Antigen CD47 Product and Services
2.35.4 ABclonal Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 ABclonal Recent Developments/Updates
2.36 Sangon Biotech
2.36.1 Sangon Biotech Details
2.36.2 Sangon Biotech Major Business
2.36.3 Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
2.36.4 Sangon Biotech Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Sangon Biotech Recent Developments/Updates
2.37 Cloud-Clone
2.37.1 Cloud-Clone Details
2.37.2 Cloud-Clone Major Business
2.37.3 Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
2.37.4 Cloud-Clone Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 Cloud-Clone Recent Developments/Updates
2.38 Akeso
2.38.1 Akeso Details
2.38.2 Akeso Major Business
2.38.3 Akeso Leukocyte Surface Antigen CD47 Product and Services
2.38.4 Akeso Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Akeso Recent Developments/Updates
2.39 3D Medicines
2.39.1 3D Medicines Details
2.39.2 3D Medicines Major Business
2.39.3 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
2.39.4 3D Medicines Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 3D Medicines Recent Developments/Updates
2.40 Fapon Biopharma
2.40.1 Fapon Biopharma Details
2.40.2 Fapon Biopharma Major Business
2.40.3 Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
2.40.4 Fapon Biopharma Leukocyte Surface Antigen CD47 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Fapon Biopharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LEUKOCYTE SURFACE ANTIGEN CD47 BY MANUFACTURER
3.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Manufacturer (2021-2026)
3.2 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturer (2021-2026)
3.3 Global Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2025
3.4.3 Top 6 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2025
3.5 Leukocyte Surface Antigen CD47 Market: Overall Company Footprint Analysis
3.5.1 Leukocyte Surface Antigen CD47 Market: Region Footprint
3.5.2 Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
3.5.3 Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Leukocyte Surface Antigen CD47 Market Size by Region
4.1.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2032)
4.1.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2032)
4.1.3 Global Leukocyte Surface Antigen CD47 Average Price by Region (2021-2032)
4.2 North America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.3 Europe Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.4 Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.5 South America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
4.6 Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
5.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2021-2032)
5.3 Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
6.2 Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2021-2032)
6.3 Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
7.2 North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
7.3 North America Leukocyte Surface Antigen CD47 Market Size by Country
7.3.1 North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
7.3.2 North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
8.2 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
8.3 Europe Leukocyte Surface Antigen CD47 Market Size by Country
8.3.1 Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
8.3.2 Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Region
9.3.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
10.2 South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
10.3 South America Leukocyte Surface Antigen CD47 Market Size by Country
10.3.1 South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
10.3.2 South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Leukocyte Surface Antigen CD47 Market Size by Country
11.3.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Leukocyte Surface Antigen CD47 Market Drivers
12.2 Leukocyte Surface Antigen CD47 Market Restraints
12.3 Leukocyte Surface Antigen CD47 Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Leukocyte Surface Antigen CD47 and Key Manufacturers
13.2 Manufacturing Costs Percentage of Leukocyte Surface Antigen CD47
13.3 Leukocyte Surface Antigen CD47 Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Leukocyte Surface Antigen CD47 Typical Distributors
14.3 Leukocyte Surface Antigen CD47 Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Leukocyte Surface Antigen CD47 Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Leukocyte Surface Antigen CD47 Consumption Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Leukocyte Surface Antigen CD47 Consumption Value by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Table 4. Global Leukocyte Surface Antigen CD47 Consumption Value by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Table 5. Global Leukocyte Surface Antigen CD47 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
Table 9. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Thermo Fisher Scientific Recent Developments/Updates
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Leukocyte Surface Antigen CD47 Product and Services
Table 14. Merck Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Merck Recent Developments/Updates
Table 16. BD Biosciences Basic Information, Manufacturing Base and Competitors
Table 17. BD Biosciences Major Business
Table 18. BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 19. BD Biosciences Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. BD Biosciences Recent Developments/Updates
Table 21. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 22. Bio-Techne Major Business
Table 23. Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
Table 24. Bio-Techne Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Bio-Techne Recent Developments/Updates
Table 26. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 27. Bio-Rad Major Business
Table 28. Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
Table 29. Bio-Rad Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Bio-Rad Recent Developments/Updates
Table 31. Revvity BioLegend Basic Information, Manufacturing Base and Competitors
Table 32. Revvity BioLegend Major Business
Table 33. Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
Table 34. Revvity BioLegend Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Revvity BioLegend Recent Developments/Updates
Table 36. Abcam Basic Information, Manufacturing Base and Competitors
Table 37. Abcam Major Business
Table 38. Abcam Leukocyte Surface Antigen CD47 Product and Services
Table 39. Abcam Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Abcam Recent Developments/Updates
Table 41. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 42. Miltenyi Biotec Major Business
Table 43. Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
Table 44. Miltenyi Biotec Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Miltenyi Biotec Recent Developments/Updates
Table 46. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 47. Cell Signaling Technology Major Business
Table 48. Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
Table 49. Cell Signaling Technology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cell Signaling Technology Recent Developments/Updates
Table 51. Proteintech Basic Information, Manufacturing Base and Competitors
Table 52. Proteintech Major Business
Table 53. Proteintech Leukocyte Surface Antigen CD47 Product and Services
Table 54. Proteintech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Proteintech Recent Developments/Updates
Table 56. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 57. Sino Biological Major Business
Table 58. Sino Biological Leukocyte Surface Antigen CD47 Product and Services
Table 59. Sino Biological Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Sino Biological Recent Developments/Updates
Table 61. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 62. ACROBiosystems Major Business
Table 63. ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
Table 64. ACROBiosystems Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. ACROBiosystems Recent Developments/Updates
Table 66. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 67. MedChemExpress Major Business
Table 68. MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
Table 69. MedChemExpress Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. MedChemExpress Recent Developments/Updates
Table 71. OriGene Basic Information, Manufacturing Base and Competitors
Table 72. OriGene Major Business
Table 73. OriGene Leukocyte Surface Antigen CD47 Product and Services
Table 74. OriGene Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. OriGene Recent Developments/Updates
Table 76. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 77. Santa Cruz Biotechnology Major Business
Table 78. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
Table 79. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Santa Cruz Biotechnology Recent Developments/Updates
Table 81. Bio X Cell Basic Information, Manufacturing Base and Competitors
Table 82. Bio X Cell Major Business
Table 83. Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
Table 84. Bio X Cell Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bio X Cell Recent Developments/Updates
Table 86. Leinco Technologies Basic Information, Manufacturing Base and Competitors
Table 87. Leinco Technologies Major Business
Table 88. Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
Table 89. Leinco Technologies Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Leinco Technologies Recent Developments/Updates
Table 91. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 92. RayBiotech Major Business
Table 93. RayBiotech Leukocyte Surface Antigen CD47 Product and Services
Table 94. RayBiotech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. RayBiotech Recent Developments/Updates
Table 96. Cytek Biosciences Basic Information, Manufacturing Base and Competitors
Table 97. Cytek Biosciences Major Business
Table 98. Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 99. Cytek Biosciences Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Cytek Biosciences Recent Developments/Updates
Table 101. Biocare Medical Basic Information, Manufacturing Base and Competitors
Table 102. Biocare Medical Major Business
Table 103. Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
Table 104. Biocare Medical Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Biocare Medical Recent Developments/Updates
Table 106. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 107. Creative Biolabs Major Business
Table 108. Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
Table 109. Creative Biolabs Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Creative Biolabs Recent Developments/Updates
Table 111. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 112. BPS Bioscience Major Business
Table 113. BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
Table 114. BPS Bioscience Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. BPS Bioscience Recent Developments/Updates
Table 116. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 117. MyBioSource Major Business
Table 118. MyBioSource Leukocyte Surface Antigen CD47 Product and Services
Table 119. MyBioSource Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. MyBioSource Recent Developments/Updates
Table 121. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 122. Novus Biologicals Major Business
Table 123. Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
Table 124. Novus Biologicals Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Novus Biologicals Recent Developments/Updates
Table 126. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 127. Aviva Systems Biology Major Business
Table 128. Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
Table 129. Aviva Systems Biology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Aviva Systems Biology Recent Developments/Updates
Table 131. Bioss Basic Information, Manufacturing Base and Competitors
Table 132. Bioss Major Business
Table 133. Bioss Leukocyte Surface Antigen CD47 Product and Services
Table 134. Bioss Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Bioss Recent Developments/Updates
Table 136. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 137. Innovative Research Major Business
Table 138. Innovative Research Leukocyte Surface Antigen CD47 Product and Services
Table 139. Innovative Research Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Innovative Research Recent Developments/Updates
Table 141. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 142. Antibodies.com Major Business
Table 143. Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
Table 144. Antibodies.com Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Antibodies.com Recent Developments/Updates
Table 146. Abbexa Basic Information, Manufacturing Base and Competitors
Table 147. Abbexa Major Business
Table 148. Abbexa Leukocyte Surface Antigen CD47 Product and Services
Table 149. Abbexa Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Abbexa Recent Developments/Updates
Table 151. Arigo Biolaboratories Basic Information, Manufacturing Base and Competitors
Table 152. Arigo Biolaboratories Major Business
Table 153. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
Table 154. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Arigo Biolaboratories Recent Developments/Updates
Table 156. Abnova Basic Information, Manufacturing Base and Competitors
Table 157. Abnova Major Business
Table 158. Abnova Leukocyte Surface Antigen CD47 Product and Services
Table 159. Abnova Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Abnova Recent Developments/Updates
Table 161. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 162. CUSABIO Major Business
Table 163. CUSABIO Leukocyte Surface Antigen CD47 Product and Services
Table 164. CUSABIO Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. CUSABIO Recent Developments/Updates
Table 166. Elabscience Basic Information, Manufacturing Base and Competitors
Table 167. Elabscience Major Business
Table 168. Elabscience Leukocyte Surface Antigen CD47 Product and Services
Table 169. Elabscience Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Elabscience Recent Developments/Updates
Table 171. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 172. Boster Biological Technology Major Business
Table 173. Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
Table 174. Boster Biological Technology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Boster Biological Technology Recent Developments/Updates
Table 176. ABclonal Basic Information, Manufacturing Base and Competitors
Table 177. ABclonal Major Business
Table 178. ABclonal Leukocyte Surface Antigen CD47 Product and Services
Table 179. ABclonal Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. ABclonal Recent Developments/Updates
Table 181. Sangon Biotech Basic Information, Manufacturing Base and Competitors
Table 182. Sangon Biotech Major Business
Table 183. Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
Table 184. Sangon Biotech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Sangon Biotech Recent Developments/Updates
Table 186. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 187. Cloud-Clone Major Business
Table 188. Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
Table 189. Cloud-Clone Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. Cloud-Clone Recent Developments/Updates
Table 191. Akeso Basic Information, Manufacturing Base and Competitors
Table 192. Akeso Major Business
Table 193. Akeso Leukocyte Surface Antigen CD47 Product and Services
Table 194. Akeso Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Akeso Recent Developments/Updates
Table 196. 3D Medicines Basic Information, Manufacturing Base and Competitors
Table 197. 3D Medicines Major Business
Table 198. 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
Table 199. 3D Medicines Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. 3D Medicines Recent Developments/Updates
Table 201. Fapon Biopharma Basic Information, Manufacturing Base and Competitors
Table 202. Fapon Biopharma Major Business
Table 203. Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
Table 204. Fapon Biopharma Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Fapon Biopharma Recent Developments/Updates
Table 206. Global Leukocyte Surface Antigen CD47 Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 207. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturer (2021-2026) & (USD Million)
Table 208. Global Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 209. Market Position of Manufacturers in Leukocyte Surface Antigen CD47, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office and Leukocyte Surface Antigen CD47 Production Site of Key Manufacturer
Table 211. Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
Table 212. Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
Table 213. Leukocyte Surface Antigen CD47 New Market Entrants and Barriers to Market Entry
Table 214. Leukocyte Surface Antigen CD47 Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 216. Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2026) & (K Dose)
Table 217. Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2027-2032) & (K Dose)
Table 218. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2026) & (USD Million)
Table 219. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2027-2032) & (USD Million)
Table 220. Global Leukocyte Surface Antigen CD47 Average Price by Region (2021-2026) & (US$/Dose)
Table 221. Global Leukocyte Surface Antigen CD47 Average Price by Region (2027-2032) & (US$/Dose)
Table 222. Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 223. Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 224. Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2021-2026) & (USD Million)
Table 225. Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2027-2032) & (USD Million)
Table 226. Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2026) & (US$/Dose)
Table 227. Global Leukocyte Surface Antigen CD47 Average Price by Type (2027-2032) & (US$/Dose)
Table 228. Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 229. Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 230. Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2021-2026) & (USD Million)
Table 231. Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2027-2032) & (USD Million)
Table 232. Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2026) & (US$/Dose)
Table 233. Global Leukocyte Surface Antigen CD47 Average Price by Application (2027-2032) & (US$/Dose)
Table 234. North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 235. North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 236. North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 237. North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 238. North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 239. North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 240. North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 241. North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 242. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 243. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 244. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 245. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 246. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 247. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 248. Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 251. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 252. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 253. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 254. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2026) & (K Dose)
Table 255. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2027-2032) & (K Dose)
Table 256. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2026) & (USD Million)
Table 257. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2027-2032) & (USD Million)
Table 258. South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 259. South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 260. South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 261. South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 262. South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 263. South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 264. South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 265. South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 266. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 267. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 268. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 269. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 270. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 271. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 272. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 273. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 274. Leukocyte Surface Antigen CD47 Raw Material
Table 275. Key Manufacturers of Leukocyte Surface Antigen CD47 Raw Materials
Table 276. Leukocyte Surface Antigen CD47 Typical Distributors
Table 277. Leukocyte Surface Antigen CD47 Typical Customers
Table 1. Global Leukocyte Surface Antigen CD47 Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Leukocyte Surface Antigen CD47 Consumption Value by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Leukocyte Surface Antigen CD47 Consumption Value by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Table 4. Global Leukocyte Surface Antigen CD47 Consumption Value by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Table 5. Global Leukocyte Surface Antigen CD47 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Product and Services
Table 9. Thermo Fisher Scientific Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Thermo Fisher Scientific Recent Developments/Updates
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Leukocyte Surface Antigen CD47 Product and Services
Table 14. Merck Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Merck Recent Developments/Updates
Table 16. BD Biosciences Basic Information, Manufacturing Base and Competitors
Table 17. BD Biosciences Major Business
Table 18. BD Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 19. BD Biosciences Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. BD Biosciences Recent Developments/Updates
Table 21. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 22. Bio-Techne Major Business
Table 23. Bio-Techne Leukocyte Surface Antigen CD47 Product and Services
Table 24. Bio-Techne Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Bio-Techne Recent Developments/Updates
Table 26. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 27. Bio-Rad Major Business
Table 28. Bio-Rad Leukocyte Surface Antigen CD47 Product and Services
Table 29. Bio-Rad Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Bio-Rad Recent Developments/Updates
Table 31. Revvity BioLegend Basic Information, Manufacturing Base and Competitors
Table 32. Revvity BioLegend Major Business
Table 33. Revvity BioLegend Leukocyte Surface Antigen CD47 Product and Services
Table 34. Revvity BioLegend Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Revvity BioLegend Recent Developments/Updates
Table 36. Abcam Basic Information, Manufacturing Base and Competitors
Table 37. Abcam Major Business
Table 38. Abcam Leukocyte Surface Antigen CD47 Product and Services
Table 39. Abcam Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Abcam Recent Developments/Updates
Table 41. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 42. Miltenyi Biotec Major Business
Table 43. Miltenyi Biotec Leukocyte Surface Antigen CD47 Product and Services
Table 44. Miltenyi Biotec Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Miltenyi Biotec Recent Developments/Updates
Table 46. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 47. Cell Signaling Technology Major Business
Table 48. Cell Signaling Technology Leukocyte Surface Antigen CD47 Product and Services
Table 49. Cell Signaling Technology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cell Signaling Technology Recent Developments/Updates
Table 51. Proteintech Basic Information, Manufacturing Base and Competitors
Table 52. Proteintech Major Business
Table 53. Proteintech Leukocyte Surface Antigen CD47 Product and Services
Table 54. Proteintech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Proteintech Recent Developments/Updates
Table 56. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 57. Sino Biological Major Business
Table 58. Sino Biological Leukocyte Surface Antigen CD47 Product and Services
Table 59. Sino Biological Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Sino Biological Recent Developments/Updates
Table 61. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 62. ACROBiosystems Major Business
Table 63. ACROBiosystems Leukocyte Surface Antigen CD47 Product and Services
Table 64. ACROBiosystems Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. ACROBiosystems Recent Developments/Updates
Table 66. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 67. MedChemExpress Major Business
Table 68. MedChemExpress Leukocyte Surface Antigen CD47 Product and Services
Table 69. MedChemExpress Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. MedChemExpress Recent Developments/Updates
Table 71. OriGene Basic Information, Manufacturing Base and Competitors
Table 72. OriGene Major Business
Table 73. OriGene Leukocyte Surface Antigen CD47 Product and Services
Table 74. OriGene Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. OriGene Recent Developments/Updates
Table 76. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 77. Santa Cruz Biotechnology Major Business
Table 78. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Product and Services
Table 79. Santa Cruz Biotechnology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Santa Cruz Biotechnology Recent Developments/Updates
Table 81. Bio X Cell Basic Information, Manufacturing Base and Competitors
Table 82. Bio X Cell Major Business
Table 83. Bio X Cell Leukocyte Surface Antigen CD47 Product and Services
Table 84. Bio X Cell Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bio X Cell Recent Developments/Updates
Table 86. Leinco Technologies Basic Information, Manufacturing Base and Competitors
Table 87. Leinco Technologies Major Business
Table 88. Leinco Technologies Leukocyte Surface Antigen CD47 Product and Services
Table 89. Leinco Technologies Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Leinco Technologies Recent Developments/Updates
Table 91. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 92. RayBiotech Major Business
Table 93. RayBiotech Leukocyte Surface Antigen CD47 Product and Services
Table 94. RayBiotech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. RayBiotech Recent Developments/Updates
Table 96. Cytek Biosciences Basic Information, Manufacturing Base and Competitors
Table 97. Cytek Biosciences Major Business
Table 98. Cytek Biosciences Leukocyte Surface Antigen CD47 Product and Services
Table 99. Cytek Biosciences Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Cytek Biosciences Recent Developments/Updates
Table 101. Biocare Medical Basic Information, Manufacturing Base and Competitors
Table 102. Biocare Medical Major Business
Table 103. Biocare Medical Leukocyte Surface Antigen CD47 Product and Services
Table 104. Biocare Medical Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Biocare Medical Recent Developments/Updates
Table 106. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 107. Creative Biolabs Major Business
Table 108. Creative Biolabs Leukocyte Surface Antigen CD47 Product and Services
Table 109. Creative Biolabs Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Creative Biolabs Recent Developments/Updates
Table 111. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 112. BPS Bioscience Major Business
Table 113. BPS Bioscience Leukocyte Surface Antigen CD47 Product and Services
Table 114. BPS Bioscience Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. BPS Bioscience Recent Developments/Updates
Table 116. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 117. MyBioSource Major Business
Table 118. MyBioSource Leukocyte Surface Antigen CD47 Product and Services
Table 119. MyBioSource Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. MyBioSource Recent Developments/Updates
Table 121. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 122. Novus Biologicals Major Business
Table 123. Novus Biologicals Leukocyte Surface Antigen CD47 Product and Services
Table 124. Novus Biologicals Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Novus Biologicals Recent Developments/Updates
Table 126. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 127. Aviva Systems Biology Major Business
Table 128. Aviva Systems Biology Leukocyte Surface Antigen CD47 Product and Services
Table 129. Aviva Systems Biology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Aviva Systems Biology Recent Developments/Updates
Table 131. Bioss Basic Information, Manufacturing Base and Competitors
Table 132. Bioss Major Business
Table 133. Bioss Leukocyte Surface Antigen CD47 Product and Services
Table 134. Bioss Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Bioss Recent Developments/Updates
Table 136. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 137. Innovative Research Major Business
Table 138. Innovative Research Leukocyte Surface Antigen CD47 Product and Services
Table 139. Innovative Research Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Innovative Research Recent Developments/Updates
Table 141. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 142. Antibodies.com Major Business
Table 143. Antibodies.com Leukocyte Surface Antigen CD47 Product and Services
Table 144. Antibodies.com Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Antibodies.com Recent Developments/Updates
Table 146. Abbexa Basic Information, Manufacturing Base and Competitors
Table 147. Abbexa Major Business
Table 148. Abbexa Leukocyte Surface Antigen CD47 Product and Services
Table 149. Abbexa Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Abbexa Recent Developments/Updates
Table 151. Arigo Biolaboratories Basic Information, Manufacturing Base and Competitors
Table 152. Arigo Biolaboratories Major Business
Table 153. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Product and Services
Table 154. Arigo Biolaboratories Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Arigo Biolaboratories Recent Developments/Updates
Table 156. Abnova Basic Information, Manufacturing Base and Competitors
Table 157. Abnova Major Business
Table 158. Abnova Leukocyte Surface Antigen CD47 Product and Services
Table 159. Abnova Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Abnova Recent Developments/Updates
Table 161. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 162. CUSABIO Major Business
Table 163. CUSABIO Leukocyte Surface Antigen CD47 Product and Services
Table 164. CUSABIO Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. CUSABIO Recent Developments/Updates
Table 166. Elabscience Basic Information, Manufacturing Base and Competitors
Table 167. Elabscience Major Business
Table 168. Elabscience Leukocyte Surface Antigen CD47 Product and Services
Table 169. Elabscience Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Elabscience Recent Developments/Updates
Table 171. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 172. Boster Biological Technology Major Business
Table 173. Boster Biological Technology Leukocyte Surface Antigen CD47 Product and Services
Table 174. Boster Biological Technology Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Boster Biological Technology Recent Developments/Updates
Table 176. ABclonal Basic Information, Manufacturing Base and Competitors
Table 177. ABclonal Major Business
Table 178. ABclonal Leukocyte Surface Antigen CD47 Product and Services
Table 179. ABclonal Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. ABclonal Recent Developments/Updates
Table 181. Sangon Biotech Basic Information, Manufacturing Base and Competitors
Table 182. Sangon Biotech Major Business
Table 183. Sangon Biotech Leukocyte Surface Antigen CD47 Product and Services
Table 184. Sangon Biotech Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Sangon Biotech Recent Developments/Updates
Table 186. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 187. Cloud-Clone Major Business
Table 188. Cloud-Clone Leukocyte Surface Antigen CD47 Product and Services
Table 189. Cloud-Clone Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. Cloud-Clone Recent Developments/Updates
Table 191. Akeso Basic Information, Manufacturing Base and Competitors
Table 192. Akeso Major Business
Table 193. Akeso Leukocyte Surface Antigen CD47 Product and Services
Table 194. Akeso Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Akeso Recent Developments/Updates
Table 196. 3D Medicines Basic Information, Manufacturing Base and Competitors
Table 197. 3D Medicines Major Business
Table 198. 3D Medicines Leukocyte Surface Antigen CD47 Product and Services
Table 199. 3D Medicines Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. 3D Medicines Recent Developments/Updates
Table 201. Fapon Biopharma Basic Information, Manufacturing Base and Competitors
Table 202. Fapon Biopharma Major Business
Table 203. Fapon Biopharma Leukocyte Surface Antigen CD47 Product and Services
Table 204. Fapon Biopharma Leukocyte Surface Antigen CD47 Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Fapon Biopharma Recent Developments/Updates
Table 206. Global Leukocyte Surface Antigen CD47 Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 207. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturer (2021-2026) & (USD Million)
Table 208. Global Leukocyte Surface Antigen CD47 Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 209. Market Position of Manufacturers in Leukocyte Surface Antigen CD47, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office and Leukocyte Surface Antigen CD47 Production Site of Key Manufacturer
Table 211. Leukocyte Surface Antigen CD47 Market: Company Product Type Footprint
Table 212. Leukocyte Surface Antigen CD47 Market: Company Product Application Footprint
Table 213. Leukocyte Surface Antigen CD47 New Market Entrants and Barriers to Market Entry
Table 214. Leukocyte Surface Antigen CD47 Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 216. Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2026) & (K Dose)
Table 217. Global Leukocyte Surface Antigen CD47 Sales Quantity by Region (2027-2032) & (K Dose)
Table 218. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2026) & (USD Million)
Table 219. Global Leukocyte Surface Antigen CD47 Consumption Value by Region (2027-2032) & (USD Million)
Table 220. Global Leukocyte Surface Antigen CD47 Average Price by Region (2021-2026) & (US$/Dose)
Table 221. Global Leukocyte Surface Antigen CD47 Average Price by Region (2027-2032) & (US$/Dose)
Table 222. Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 223. Global Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 224. Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2021-2026) & (USD Million)
Table 225. Global Leukocyte Surface Antigen CD47 Consumption Value by Type (2027-2032) & (USD Million)
Table 226. Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2026) & (US$/Dose)
Table 227. Global Leukocyte Surface Antigen CD47 Average Price by Type (2027-2032) & (US$/Dose)
Table 228. Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 229. Global Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 230. Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2021-2026) & (USD Million)
Table 231. Global Leukocyte Surface Antigen CD47 Consumption Value by Application (2027-2032) & (USD Million)
Table 232. Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2026) & (US$/Dose)
Table 233. Global Leukocyte Surface Antigen CD47 Average Price by Application (2027-2032) & (US$/Dose)
Table 234. North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 235. North America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 236. North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 237. North America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 238. North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 239. North America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 240. North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 241. North America Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 242. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 243. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 244. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 245. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 246. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 247. Europe Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 248. Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Europe Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 251. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 252. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 253. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 254. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2021-2026) & (K Dose)
Table 255. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity by Region (2027-2032) & (K Dose)
Table 256. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2021-2026) & (USD Million)
Table 257. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value by Region (2027-2032) & (USD Million)
Table 258. South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 259. South America Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 260. South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 261. South America Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 262. South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 263. South America Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 264. South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 265. South America Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 266. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2021-2026) & (K Dose)
Table 267. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Type (2027-2032) & (K Dose)
Table 268. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2021-2026) & (K Dose)
Table 269. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Application (2027-2032) & (K Dose)
Table 270. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2021-2026) & (K Dose)
Table 271. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Quantity by Country (2027-2032) & (K Dose)
Table 272. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2021-2026) & (USD Million)
Table 273. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value by Country (2027-2032) & (USD Million)
Table 274. Leukocyte Surface Antigen CD47 Raw Material
Table 275. Key Manufacturers of Leukocyte Surface Antigen CD47 Raw Materials
Table 276. Leukocyte Surface Antigen CD47 Typical Distributors
Table 277. Leukocyte Surface Antigen CD47 Typical Customers
LIST OF FIGURES
Figure 1. Leukocyte Surface Antigen CD47 Picture
Figure 2. Global Leukocyte Surface Antigen CD47 Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type in 2025
Figure 4. B-6H12 Examples
Figure 5. ALX-148 Examples
Figure 6. CC-90002 Examples
Figure 7. PSTx-23 Examples
Figure 8. Others Examples
Figure 9. Global Leukocyte Surface Antigen CD47 Revenue by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Commercial Product Form in 2025
Figure 11. Anti-CD47 Antibodies Examples
Figure 12. Recombinant CD47 Proteins Examples
Figure 13. CD47 Assay Kits Examples
Figure 14. Others Examples
Figure 15. Global Leukocyte Surface Antigen CD47 Revenue by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Molecular Modality in 2025
Figure 17. Antibodies Examples
Figure 18. Fusion Proteins Examples
Figure 19. Small Molecules and Peptides Examples
Figure 20. Others Examples
Figure 21. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturing System in 2025
Figure 23. Mammalian Cell Expression Products Examples
Figure 24. Hybridoma-derived Products Examples
Figure 25. Microbial Expression Products Examples
Figure 26. Others Examples
Figure 27. Global Leukocyte Surface Antigen CD47 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 28. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application in 2025
Figure 29. Lymphoma Examples
Figure 30. Ovarian Cancer Examples
Figure 31. Ischemia Reperfusion Injury Examples
Figure 32. Kindney Transplant Rejection Examples
Figure 33. Others Examples
Figure 34. Global Leukocyte Surface Antigen CD47 Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global Leukocyte Surface Antigen CD47 Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Leukocyte Surface Antigen CD47 Sales Quantity (2021-2032) & (K Dose)
Figure 37. Global Leukocyte Surface Antigen CD47 Price (2021-2032) & (US$/Dose)
Figure 38. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Manufacturer in 2025
Figure 39. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturer in 2025
Figure 40. Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 41. Top 3 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2025
Figure 42. Top 6 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2025
Figure 43. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Region (2021-2032)
Figure 44. Global Leukocyte Surface Antigen CD47 Consumption Value Market Share by Region (2021-2032)
Figure 45. North America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 48. South America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 49. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 50. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 51. Global Leukocyte Surface Antigen CD47 Consumption Value Market Share by Type (2021-2032)
Figure 52. Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032) & (US$/Dose)
Figure 53. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 54. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032)
Figure 55. Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032) & (US$/Dose)
Figure 56. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 57. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 58. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 59. North America Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 60. United States Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 61. Canada Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 62. Mexico Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 63. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 64. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 65. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 66. Europe Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 67. Germany Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 68. France Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 69. United Kingdom Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 70. Russia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 71. Italy Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 72. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 73. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 74. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Region (2021-2032)
Figure 75. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value Market Share by Region (2021-2032)
Figure 76. China Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 77. Japan Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 78. South Korea Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 79. India Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 80. Southeast Asia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 81. Australia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 82. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 83. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 84. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 85. South America Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 86. Brazil Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 87. Argentina Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 1. Leukocyte Surface Antigen CD47 Picture
Figure 2. Global Leukocyte Surface Antigen CD47 Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type in 2025
Figure 4. B-6H12 Examples
Figure 5. ALX-148 Examples
Figure 6. CC-90002 Examples
Figure 7. PSTx-23 Examples
Figure 8. Others Examples
Figure 9. Global Leukocyte Surface Antigen CD47 Revenue by Commercial Product Form, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Commercial Product Form in 2025
Figure 11. Anti-CD47 Antibodies Examples
Figure 12. Recombinant CD47 Proteins Examples
Figure 13. CD47 Assay Kits Examples
Figure 14. Others Examples
Figure 15. Global Leukocyte Surface Antigen CD47 Revenue by Molecular Modality, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Molecular Modality in 2025
Figure 17. Antibodies Examples
Figure 18. Fusion Proteins Examples
Figure 19. Small Molecules and Peptides Examples
Figure 20. Others Examples
Figure 21. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturing System, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturing System in 2025
Figure 23. Mammalian Cell Expression Products Examples
Figure 24. Hybridoma-derived Products Examples
Figure 25. Microbial Expression Products Examples
Figure 26. Others Examples
Figure 27. Global Leukocyte Surface Antigen CD47 Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 28. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application in 2025
Figure 29. Lymphoma Examples
Figure 30. Ovarian Cancer Examples
Figure 31. Ischemia Reperfusion Injury Examples
Figure 32. Kindney Transplant Rejection Examples
Figure 33. Others Examples
Figure 34. Global Leukocyte Surface Antigen CD47 Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global Leukocyte Surface Antigen CD47 Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Leukocyte Surface Antigen CD47 Sales Quantity (2021-2032) & (K Dose)
Figure 37. Global Leukocyte Surface Antigen CD47 Price (2021-2032) & (US$/Dose)
Figure 38. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Manufacturer in 2025
Figure 39. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturer in 2025
Figure 40. Producer Shipments of Leukocyte Surface Antigen CD47 by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 41. Top 3 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2025
Figure 42. Top 6 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2025
Figure 43. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Region (2021-2032)
Figure 44. Global Leukocyte Surface Antigen CD47 Consumption Value Market Share by Region (2021-2032)
Figure 45. North America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 48. South America Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 49. Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 50. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 51. Global Leukocyte Surface Antigen CD47 Consumption Value Market Share by Type (2021-2032)
Figure 52. Global Leukocyte Surface Antigen CD47 Average Price by Type (2021-2032) & (US$/Dose)
Figure 53. Global Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 54. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032)
Figure 55. Global Leukocyte Surface Antigen CD47 Average Price by Application (2021-2032) & (US$/Dose)
Figure 56. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 57. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 58. North America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 59. North America Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 60. United States Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 61. Canada Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 62. Mexico Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 63. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 64. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 65. Europe Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 66. Europe Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 67. Germany Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 68. France Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 69. United Kingdom Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 70. Russia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 71. Italy Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 72. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 73. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 74. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Region (2021-2032)
Figure 75. Asia-Pacific Leukocyte Surface Antigen CD47 Consumption Value Market Share by Region (2021-2032)
Figure 76. China Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 77. Japan Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 78. South Korea Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 79. India Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 80. Southeast Asia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 81. Australia Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 82. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Type (2021-2032)
Figure 83. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Application (2021-2032)
Figure 84. South America Leukocyte Surface Antigen CD47 Sales Quantity Market Share by Country (2021-2032)
Figure 85. South America Leukocyte Surface Antigen CD47 Consumption Value Market Share by Country (2021-2032)
Figure 86. Brazil Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
Figure 87. Argentina Leukocyte Surface Antigen CD47 Consumption Value (2021-2032) & (USD Million)
